Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer.
about
Translational progress on tumor biomarkersA new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study.Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy.Assessing N w-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker.Improving biosensing activity to carcinoembryonic antigen with orientated single domain antibodies.Inhibitory Effect of Viola odorata Extract on Tumor Growth and Metastasis in 4T1 Breast Cancer Model.
P2860
Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@ast
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@en
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@nl
type
label
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@ast
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@en
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@nl
prefLabel
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@ast
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@en
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@nl
P2093
P2860
P356
P1476
Association of CA 15-3 and CEA ...... with metastatic breast cancer.
@en
P2093
Man-Man Liang
Wen-Ying Zhao
Xiao-Bing Ye
P2860
P304
P356
10.3892/MCO.2014.419
P577
2014-09-18T00:00:00Z